Ignazio Piseddu

[Ignazio Piseddu @i_piseddu]

Finally, we gratefully acknowledge the generous support of @EKFStiftung and funding from the DFG @LETSimmun @237Crc

[Ignazio Piseddu @i_piseddu]

Thrilled to see our paper on CAR-T cells and STING agonists in PDAC highlighted by @AGA_Gastro today!

Very grateful to the brilliant and inspiring @v_hornung @hornung_lab for his mentorship and scientific vision throughout this work.

@LMU_Muenchen @GeneCenter_LMU #LMUKlinikum

[Gastroenterology @AGA_Gastro]

Study finds that STING-deficient CAR-T cells + diABZI boost antitumor activity, increase CAR-T persistence, and improve tumor control in pancreatic cancer models. Click the link to read more:
🔗 https://t.co/ysCSmWaELk
@v_hornung @i_piseddu @hornung_lab

[Ignazio Piseddu @i_piseddu]

A special thank you to all our fantastic co-authors and collaborators @JuliaMayerle, @KlinPharm, @MSubklewe @AdrianGottsch for their expertise, dedication, and inspiring discussions throughout this project, which truly made this team effort possible.

[JHEP Reports @JHEP_Reports]

🟣Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced #HCC
🔓#OpenAccess at👉https://t.co/eDUWodGOvD

#HCC #LiverTwitter #LiverHealth #LiverX

[robert verdonk @rcverdonk]

One of the most complex entities to deal with as a gastroenterologist! 👉🏻The dual role of IgG4 in immunity: bridging pathophysiology and therapeutic applications | Gut https://t.co/tNsGW7nRVC

[Gut Journal @Gut_BMJ]

#GUTImages from the #GUTRecentAdvancesInClinicalPractice paper by Piseddu et al on

"The dual role of IgG4 in immunity: bridging pathophysiology and therapeutic applications" via

https://t.co/rUKF2He5eE

#IgG4

[Cancer Immunology Research @CIR_AACR]

Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis: https://t.co/vZ8ZypiCxp

[LMU Clinical Pharmacology @KlinPharm]

Great collaborative effort 🥂@i_piseddu #Anzlab @EnricoNDeToni @KBoettcherLab @JuliaMayerle

[Najib Ben Khaled @N_BenKhaled]

Great to see our new study on a vulnerable phase in HCC immunotherapy highlighted. Thank you @Erman_Akkus, and thanks to all collaborators!

[Erman Akkus @Erman_Akkus]

🏥Early mortality in atezo-beva for HCC
@JHEP_Reports

🚨CPS B and high CRP ➡️ early mortality (90days)
❗️Among patients with CPS B: B9, ECOG ≥2, high creatinin

👉https://t.co/VHQUU5gQmZ

#cancer #oncology #MedX #liver @OncoAlert

[Gene Center Munich @GeneCenter_LMU]

🥳Amazing publication from the @hornung_lab, in collab. with the @CarellThomas lab, on the innate immune system: how modified RNA tricks the immune system. Big shout-out to the two first authors, @BeroutiMarleen and Mirko Wagner!
https://t.co/sndCWedA6q
https://t.co/zKcPW6F7nb

[Waggoner Lab @LabWaggoner]

Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement @CellCellPress @CarellThomas @v_hornung @BeroutiMarleen
https://t.co/o7TRnHztUt

[Universität München @LMU_Muenchen]

🔬 Nukleinsäuren können mehr als Gene speichern – und #NUCLEATE will das volle Potenzial nutzen. Mit dem neuen #Exzellenzcluster erforschen #LMU, @TU_Muenchen & @Uni_WUE DNA & RNA interdisziplinär – von Gentherapie bis KI.
#Forschung #Biotech https://t.co/J6zKXdKQec

[Veit Hornung @v_hornung]

📢 Postdoc opening! 📢

@SorekLab and @hornung_lab are looking for outstanding candidates for a position at the intersection of computational biology & innate immunity. Dive into impactful research across two dynamic fields.

Interested? Let’s connect!

👇
https://t.co/FJuJCuwJc4

[Gene Center Munich @GeneCenter_LMU]

📢Don't miss this great job opportunity:
@hornung_lab invites applications for a ‼️postdoctoral position‼️ to investigate the fundamental question of how the innate immune system distinguishes self from non-self
🧐https://t.co/q2DLaRopzO
@v_hornung

[Veit Hornung @v_hornung]

We’ve just finalized the program for our EMBO Inflammasome Workshop.

🙌 Next to many amazing short talks, we have an incredible lineup of poster presentations featuring lots of unpublished work.

Check out the full agenda on our website—there’s still time to register!

👇

[Veit Hornung @v_hornung]

Final call to register for our EMBO Workshop!

The Inflammasomes - 2024
24 – 27 September 2024 | Planegg-Martinsried, Germany

[Veit Hornung @v_hornung]

🚨 Reminder! 🚨
Be sure to submit your abstract for our upcoming EMBO workshop "The Inflammasomes 2024"! 📅

- Many opportunities for short talks 🎤
- Several travel grants available 🌍
- Lots of networking opportunities 🤝
- 🥨& 🍻

https://t.co/Ju8QQatm55

[Najib Ben Khaled @N_BenKhaled]

Read our paper in @JHEP_Reports on the risk of bleeding and thromboembolism in atezobev vs lenvatinib for HCC. Big thanks to the fantastic collaborators!

[Veit Hornung @v_hornung]

Excited to share our latest study in @ImmunityCP showing how PLD exonucleases together with RNase T2 process RNA upstream of TLR7. ✂️🧬

Kudos to @BeroutiMarleen for her fantastic work!

https://t.co/nXXoCEcgmJ